tiprankstipranks
Exagen sees FY24 revenue $55M-$56M, consensus $57.22M
The Fly

Exagen sees FY24 revenue $55M-$56M, consensus $57.22M

The Company now expects 2024 full-year revenue of $55 million to $56 million, primarily reflecting the impact of one-time adjustments in the third quarter and reiterates adjusted EBITDA loss expectations of better than $12 million.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Read More on XGN:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App